Skip to main content

Table 1 Clinical features of patients with lung cancer and WT1 expression in lung cancer tissues

From: Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway

Patient Age (year) Sex Histology TNM Stage WT1 mRNA level
1 69 F Ad T1N1M0 IIA 8.3×10-1
2 55 M Ad T1N1M0 IIA 2.8×100
3 56 F Ad T2N1M0 IIB 0.7×100
4 50 M Ad T2N0M0 IB 9.3×10-1
5 63 F Ad T2N1M0 IIB 0.9×100
6 63 M Sq T1N0M0 IA 0.8×10-2
7 56 M Sq T1N0M0 IA 3.8×10-1
8 64 F Sq T2N1M0 IIB 3.4×100
9 47 M Sq T1N0M0 IA 0.5×10-1
10 56 M Sq T1N0M0 IA 4.5×10-1
11 63 M Sq T2N1M0 IIB 2.1×100
12 64 M Sq T1N0M0 IA 0.3×10-2
13 54 M Sq T2N1M0 IIB 3.7×100
14 71 M Sq T1N2M0 IIIA 5.4×100
15 61 M Sq T1N1M0 IIA 1.4×100
16 75 M Sq T2N1M0 IIB 3.5×100
17 53 M Sq T2N0M0 IB 0.2×10-1
18 59 M Sq T1N2M0 IIIA 3.1×100
19 76 M Sq T2N0M0 IB 0.5×100
20 66 M Sq T2N0M0 IB 7.3×10-1
  1. Lung cancer tissues were obtained from patients with lung cancer at Tangdu Hospital, with informed consent. NSCLC stages were classified according to the UICC TNM classification and Clinicopathologic features of each lung cancers are listed. WT1 expression levels in NSCLCs were examined by means of quantitative real-time RT-PCR and listed in the last column.